ロード中...
Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells
Our previous studies have shown Leptomycin B (LMB) is a promising antilung cancer drug. Epigallocatechin-3-gallate (EGCG) has antitumor properties but a debatable clinical application. The objective of this study is to evaluate the combination therapeutic effect of LMB and EGCG and its molecular mec...
保存先:
| 出版年: | Oxid Med Cell Longev |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4397486/ https://ncbi.nlm.nih.gov/pubmed/25922640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/217304 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|